Fosun International Ltd

Q4 2019 13F Holdings Report, Stock Holdings

Signature - Title
Angel Sze - Company Secretary
Location
Hong Kong, China
Holdings as of
31 Dec 2019
Value $
$1,181,529,000
Num holdings
228
Filing time
18 Feb 2020, 09:48:30 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included AMRX, VRAYQ, NFH, WEIBO CORP, and SINA.
Previous filing
Q3 2019 - 12 Nov 2019
Next filing
Q1 2020 - 11 May 2020
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q4 compared to 2019 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Angel Sze Company Secretary Hong Kong, Hong Kong 14 Feb 2020

Other Included Managers (4):

Num Name Location File Number
1 Fidelidade-Companhia de Seguros, S.A. Lisboa 028-16288
2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai, China 028-18303
3 Hauck & Aufhaeuser Fund Services S.A. Munsbach, Luxembourg 028-18996
4 AMERITRUST GROUP, INC. Southfield, MI